Drug Profile
Research programme: antidotes for nerve agents - Nutra Pharma Corporation/International Security Group
Alternative Names: Nerve agent countermeasures - Nutra Pharma Corporation/International Security GroupLatest Information Update: 28 Jun 2021
Price :
$50
*
At a glance
- Originator Nutra Pharma Corporation
- Class Antidotes
- Mechanism of Action Cholinergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Poisoning
Most Recent Events
- 28 Jun 2021 No recent reports of development identified for preclinical development in Poisoning in USA
- 24 May 2017 Nutra Pharma Corporation and International Security Group enter into collaboration for the development of nerve agent countermeasures
- 24 May 2017 Preclinical trials in Poisoning in USA (unspecified route)